TeraRecon previews treatment planning software

Article

Japanese postprocessing firm TeraRecon demonstrated work-in-progress treatment planning software at the ASTRO meeting Nov. 4 to 8. The software, which runs on TeraRecon’s Aquarius workstation, supports treatment planning, dose calculation, and dose

Japanese postprocessing firm TeraRecon demonstrated work-in-progress treatment planning software at the ASTRO meeting Nov. 4 to 8. The software, which runs on TeraRecon’s Aquarius workstation, supports treatment planning, dose calculation, and dose optimization. It features real-time 3-D volume rendering, using the company’s VolumePro technology, as well as such advanced features as interactive image fusion, auto contouring, beam and block entry, dose calculation, and segmented image reconstruction with isodose display. The system can also digitally reconstruct radiographs and generate dose-volume histograms for 3-D structures. An intravascular brachytherapy module provides extended radial and anisotropic dose functions.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.